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        Adult stem cells (SCs) have been described to 
contribute to tissue regeneration after injury in 
various organ systems (  1  ). The recruitment of 
SCs to the injured tissue herein appears to be 
the prerequisite for SC-based repair, and the 
comprehension of mechanisms that regulate 
their migration is crucial for the success of any 
clinical strategy involving SCs (  2  ). In this con-
text, the chemokine stromal-derived factor-1 
(SDF-1) has been implicated as a principal reg-
ulator of retention, migration, and mobilization 
of hematopoietic SCs (HSCs) and endothelial 
progenitor cells during steady-state homeostasis 
and injury (  2  ). In addition, SDF-1 is considered 
as a critical mediator of recruitment and trans-
endothelial migration in successful therapeutic 
strategies that involve the ex vivo injection of 
resident tissue SCs (  1  –  4  ). CXCR4 has long been 
considered as the unique receptor of SDF-1 and 
as the only mediator of SDF-1-induced biolog-
ical eff  ects (  5  –  6  ). Recently, however, SDF-1 was 
reported to also be a ligand of a novel chemo-
kine receptor, CXCR7 (  7  ). In human tissues, 
CXCR7 expression has been described on endo-
thelial cells (ECs) and on some tumor cell lines, 
but its contribution to SDF-1  –  mediated eff  ects 
is still unknown. 
  Acute renal failure (ARF) is a leading cause 
of morbidity and mortality. The combined an-
nual incidence of ARF and acute-on-chronic 
renal failure is 2,147 pmp, with a reported over-
all mortality as high as 50% (  8  ). SC-based kid-
ney regeneration may be critical to reduce 
the incidence and severity of renal diseases (  9  ). 
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  Recently, we have identifi  ed a population of renal progenitor cells in human kidneys showing 
regenerative potential for injured renal tissue of SCID mice. We demonstrate here that 
among all known chemokine receptors, human renal progenitor cells exhibit high expression 
of both stromal-derived factor-1 (SDF-1) receptors, CXCR4 and CXCR7. In SCID mice with 
acute renal failure (ARF), SDF-1 was strongly up-regulated in resident cells surrounding 
necrotic areas. In the same mice, intravenously injected renal stem/progenitor cells 
engrafted into injured renal tissue decreased the severity of ARF and prevented renal fi  brosis. 
These benefi  cial effects were abolished by blocking either CXCR4 or CXCR7, which dramati-
cally reduced the number of engrafting renal progenitor cells. However, although SDF-1  –
  induced migration of renal progenitor cells was only abolished by an anti-CXCR4 antibody, 
transendothelial migration required the activity of both CXCR4 and CXCR7, with CXCR7 
being essential for renal progenitor cell adhesion to endothelial cells. Moreover, CXCR7 
but not CXCR4 was responsible for the SDF-1  –  induced renal progenitor cell survival. 
Collectively, these fi  ndings suggest that CXCR4 and CXCR7 play an essential, but differential, 
role in the therapeutic homing of human renal progenitor cells in ARF, with important 
implications for the development of stem cell  –  based therapies. 480 CXCR4 AND CXCR7 IN THERAPEUTIC HOMING OF RENAL STEM CELLS | Mazzinghi et al.
Several studies have examined the possibility that BM-derived 
SCs (BMSCs) might be used for renal repair (  9  –  17  ). How  -
ever, these studies disagree on whether there is evidence for 
BMSC diff  erentiation into renal resident cells, and a recent 
study even suggests that treatment of renal failure with BM-
SCs can be off  set by a partial maldiff  erentiation of BMSCs 
into adipocytes accompanied by glomerular sclerosis (  18  ). 
Thus, kidney-specifi  c stem/progenitor cells may be better for 
tissue replacement because of their inherent organ-specifi  c 
identity, which obviates the risk of maldiff  erentiation. Although 
the existence of renal SCs has been an important matter of 
debate (  9,19-24  ), we recently provided evidence of the ex-
istence in the Bowman  ’  s capsule of human kidney of a pop-
ulation of renal multipotent progenitors (RMPs) (  25  ). These 
RMPs are characterized by the expression of two SC mark-
ers, CD24 and CD133, which allows their isolation by fl  ow 
cytometry for clinical purposes (  25  ). When injected into 
mice models of ARF, RMPs displayed regenerative potential 
and signifi  cantly improved renal function (  25  ). The compre-
hension of mechanisms that mediate RMP migration, homing, 
and repopulation in ex vivo treatments are crucial for the success 
of a clinical strategy of SC-based kidney regeneration. 
  In this study, to identify RMP homing factors, the chemo-
kine receptor expression pattern of these cells was investigated. 
Our results demonstrate that RMPs exhibit high expression 
of the two receptors for SDF-1, CXCR4, and CXCR7, and 
that both of these receptors are required for therapeutic hom-
ing of RMPs in SCID models of ARF by regulating trans-
endothelial migration and survival of i.v. injected RMPs in a 
nonredundant manner, with important implications for the 
setup of SC-based therapies. 
    RESULTS   
  Human RMPs express high levels of CXCR4 and CXCR7 
  To determine the mechanisms involved in the therapeutic 
homing of RMPs into the injured kidney, we fi  rst assessed on 
these cells the expression of mRNA for cc, CXC, and CX3C 
chemokine receptors by using real-time quantitative RT-
PCR. RMPs exhibited high expression of the transcripts for 
CXCR4 and CXCR7 and lower expression of CXCR3-B, 
whereas transcripts for CXCR1, CXCR2, CXCR3-A, 
CXCR5, CXCR6, CCR1, CCR2, CCR3, CCR4, CCR5, 
CCR6, CCR7, CCR8, CCR9, CCR10, and CX3CR1 
were not detectable (  Fig. 1 A  ).   Therefore, CXCR4 and 
CXCR7 protein expression by RMP was assessed by confo-
cal microscopy. CXCR4 protein appeared to be expressed 
on 95  –  100% of these cells (  Fig. 1 B  ). Likewise, CXCR7 pro-
tein expression could be detected on RMPs by using two 
diff  erent anti-CXCR7 antibodies (  Fig. 1, C and D  ). Because 
it is known that CXCR7 mRNA expression frequently does 
not correlate with protein expression, and antibody specifi  c-
ity has been a topic of debate on CXCR7 (  7  ), to further 
confi  rm that RMPs expressed both CXCR4 and CXCR7 
on their surface, a comprehensive competition binding assay 
was performed (  7  ). Using   125  I-SDF-1 as the   “  signature  ”   ligand, 
displacement curves obtained by increasing concentrations 
    Figure 1.     RMPs express CXCR4 and CXCR7.   (A) Assessment of 
mRNA levels for chemokine receptors by real-time quantitative 
RT-PCR in cultures of RMPs. Results are expressed as the mean   ±   
the SEM of triplicate assessments in primary cultures from 10 different 
donors. (B) Laser confocal microscopy demonstrates CXCR4 protein 
expression by RMPs (green). (C and D) Laser confocal microscopy 
demonstrates CXCR7 protein expression by RMPs (green) by using 
two polyclonal antibodies recognizing distinct portions of the 
receptor. To-Pro-3 counterstains nuclei. Bar, 20     m. (E) Binding of 
  125  I-SDF-1 to RMPs in the presence of increasing concentrations of 
unlabeled SDF-1. Data show simultaneous analysis of three distinct 
self-displacement curves. (F) Binding of   125  I-SDF-1 to RMPs can be 
displaced by increasing concentrations of unlabeled I-TAC revealing 
a typical CXCR7 binding profi  le. Data are representative of simultaneous 
analysis of three distinct self displacement curves. (G)   125 I-SDF-1 
binding to RMPs is completely inhibited by unlabeled SDF-1. 
Coexpression of CXCR7 and CXCR4 on the surface of RMPs is defined 
by the partial inhibition of the   125  I-SDF-1 binding after complete 
displacement with cold I-TAC or with the CXCR4 antagonist AMD3100 
(50     M). Data represent the mean   ±   the SEM, as obtained in three 
separate experiments. **, P   <   0.001.     JEM VOL. 205, February 18, 2008 
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injection) (  25  ), in the experiments reported herein, RMP cells 
were injected earlier, i.e., 4 and 20 h after glycerol injection. 
Measurement of blood urea nitrogen (BUN) levels demon-
strated that mice undergoing early treatment with RMPs 
showed a signifi  cantly reduced severity of ARF and a com-
plete recovery of renal function that was not observed in 
mice treated with saline (  Fig. 3 A  ).   In comparison to the pre-
viously reported model (  25  ), the early injection of RMPs re-
sulted in a signifi  cant reduction of the severity of ARF, as 
revealed by the consistently lower BUN levels and smaller 
necrotic areas on day 4 (  Fig. 3, A and B  ). Accordingly, a signifi  -
cant reduction in phalloidin fl  uorescent staining was observed 
of unlabeled SDF-1 demonstrated specifi  c binding to RMPs 
(  Fig. 1 E  ). To further confi  rm the presence of the CXCR7 
binding site,   125  I-SDF-1 heterologous displacement curves 
were obtained with increasing concentrations of cold inter-
feron-induced T cell      chemoattractant (I-TAC), a chemo-
kine that shares selective binding of CXCR7 with SDF-1. 
I-TAC partially displaced   125  I-SDF-1 binding, which is in 
agreement with the presence of both CXCR7 and CXCR4 
on the surface of RMPs (  Fig. 1 F  ). In addition, the binding 
of   125  I-SDF-1 to RMPs was only partially inhibited by pre-
treatment of the cells with the selective CXCR4 antagonist 
AMD3100 (  Fig. 1 G  ), further confi  rming the presence of both 
CXCR4 and CXCR7 on the surface of RMPs. 
  SDF-1 expression is up-regulated in kidneys with ARF induced 
by rhabdomyolysis 
  The high expression of both CXCR4 and CXCR7 on the 
great majority of RMPs allowed us to hypothesize that their 
ligand, SDF-1, may be involved in the therapeutic homing of 
these cells via its interaction with one or both SDF-1 receptors. 
To support this possibility, we fi  rst assessed SDF-1 expression 
in renal tissues obtained from mice with rhabdomyolysis-
induced ARF. Mice were treated with glycerol injection, and 
a double label immunofl  uorescence for SDF-1 and the cyto-
skeletal marker phalloidin was performed at diff  erent time 
points. Phalloidin staining was used inasmuch as the absence 
or reduction of this marker allows the identifi  cation of the 
necrotic areas (  16  ). Whereas in kidneys obtained from healthy 
mice before glycerol injection, SDF-1 expression was only 
  observed in some cells within glomerular structures (  Fig. 2 A  ), 
intense SDF-1 expression was found in ECs, as well as in tu-
bular structures surrounding the areas of tubular necrosis in 
mice with ARF (  Fig. 2, B and C  ).   SDF-1 appeared to be 
detectable within the fi  rst 24 h after glycerol injection, and 
its expression peaked between 48 and 72 h (  Fig. 2, B and C  ). 
In the subsequent days, SDF-1 expression was rapidly down-
regulated, and starting at day 10 after injury, its expression 
became comparable to that observed in healthy mice (  Fig. 2 D  ). 
To assess whether SDF-1 expression correlated with exposure 
to hemoglobin and myoglobin, primary cultures of mouse renal 
proximal tubular cells (RPTECs) were treated with 100 ng/ml 
of hemoglobin or myoglobin for 24 h. Marked SDF-1 mRNA 
and protein expression occurred in RPTECs after their expo-
sure to hemoglobin or myoglobin (  Fig. 2, E and F  ), thus ac-
counting for the strong up-regulation of SDF-1 observed in 
kidneys of mice with rhabdomyolysis-induced ARF. 
  Neutralization of either CXCR4 or CXCR7 inhibits tissue 
regeneration and renal function improvement in kidneys
of SCID mice with ARF 
  To assess whether the interaction of SDF-1 with CXCR4 
and/or CXCR7 was involved in the regenerative capacity of 
RMPs, mice were injected with RMPs or with saline. Unlike 
the model reported in our previous study, in which RMP 
cells were injected at the peak of injury (3 and 4 d after glycerol 
    Figure 2.     Exposure to hemoglobin and myoglobin up-regulates 
SDF-1 expression in rhabdomyolysis-induced ARF.   (A) Expression of 
SDF-1 (red) in a healthy mouse kidney stained with the cytoskeleton 
marker phalloidin (green). (B) Expression of SDF-1 (red) in the kidney of a 
mouse affected by rhabdomyolysis-induced ARF 24 h after injection of 
glycerol, and stained with the cytoskeleton marker phalloidin (green). 
(inset) High-power magnifi  cation of a vessel showing SDF-1 staining (red) 
and vWf (green). (C) Expression of SDF-1 (red) in the kidney of a mouse 
affected by rhabdomyolysis-induced ARF 48 h after injection of glycerol, 
and stained with the cytoskeleton marker phalloidin (green). (D) Ex-
pression of SDF-1 (red) in the kidney of a mouse affected by rhabdo  -
myolysis-induced ARF 14 d after injection of glycerol, and stained with 
the cytoskeleton marker Phalloidin (green). To-Pro-3 counterstains nuclei. 
Bar, 50     m . (E) Assessment by real-time quantitative RT-PCR of SDF-1 
mRNA expression in primary cultures of murine RPTEC before and after expo-
sure to 100 ng/ml hemoglobin or myoglobin. Results are expressed as 
the mean   ±   the SEM of three independent experiments. (F) Assessment 
by ELISA of SDF-1 protein expression in primary cultures of murine 
RPTECs before and after exposure to 100 ng/ml hemoglobin or 100 ng/ml 
myoglobin. Results are expressed as the mean   ±   the SEM of three 
independent experiments.     482 CXCR4 AND CXCR7 IN THERAPEUTIC HOMING OF RENAL STEM CELLS | Mazzinghi et al.
focal, but large, areas of interstitial fi  brosis, whereas kidney 
sections of mice injected with RMPs usually showed normal 
renal morphology (fi  brosis score: 2.71   ±   0.18 vs. 0.45   ±   0.15; 
P   <   0.001;   Fig. 3 B  ). 
in mice treated with saline in comparison to mice treated with 
RMPs (63,779   ±   5,608 vs. 138,900   ±   12,876; P   <   0.05). In ad-
dition, evaluation of residual fi  brosis with Masson  ’  s trichrome 
staining on day 14 showed that mice treated with saline exhibited 
    Figure 3.     Both CXCR7 and CXCR4 are required for the therapeutic effect of RMPs in ARF.   (A) BUN levels as measured in untreated (    ) or in 
glycerol-treated mice that received saline (red circles), or RMPs (fi  lled squares). Black arrows point to the days of saline or RMP injection. *, P   <   0.05 and 
**, P   <   0.001 versus glycerol plus saline.   n   = 10 at each time point. (B; top) Representative micrographs of kidneys from mice treated with saline or with 
RMPs and stained with phalloidin (day 4). (bottom) Representative micrographs of kidneys from mice treated with saline or with RMPs and stained with 
Masson  ’  s trichrome (day 14). (C) Comparison of BUN levels at day 4 among mice treated with saline, RMP + IgG-Isotype control, RMP + IgG-anti-HLA-I, 
RMP + anti-CXCR7 antibody, RMP + IgG2a-Isotype control, RMP + IgG2a-anti-HLA-I, RMP + anti-CXCR4 antibody, and RMP + AMD3100.   n   = at least 10 
for each treatment. a vs. b, a vs. e, e vs. g, e vs. h: P   <   0.001; a vs. c, a vs. f, b vs. d, c vs. d, b vs. h, c vs. h, f vs. g, f vs. h: P   <   0.05; a vs. d, a vs. g, a vs. h, 
b vs. e, c vs. e, e vs. f, b vs. c, b vs. f, c vs. f, d vs. g, d vs. h: NS. (D) Representative micrographs of kidneys from mice treated with RMP + IgG2a-Isotype 
control, RMP + anti-CXCR4, RMP + IgG-Isotype control or RMP + anti-CXCR7, and stained with phalloidin (day 4). (E) Comparison of BUN levels at day 14 
among mice treated with saline, RMP + IgG-Isotype control, RMP + IgG-anti-HLA-I, RMP + anti-CXCR7 antibody, RMP + IgG2a-Isotype control, RMP + 
IgG2a-anti-HLA-I, RMP + anti-CXCR4 antibody, RMP + AMD3100.   n   = at least 10 for each treatment. a vs. b, a vs. c, a vs. e, a vs. f, b vs. d, b vs. h, c vs. d, 
c vs. h, e vs. g, e vs. h, f vs. h: P   <   0.001; f vs. g: P   <   0.05; a vs. d, a vs. g, a vs. h, b vs. c, b vs. e, c vs. e, c vs. f, e vs. f, d vs. g, d vs. h, g vs. h: NS. (F) Represen-
tative micrographs of kidneys from mice treated with RMP + IgG2a-Isotype control, RMP + anti-CXCR4, RMP + IgG-Isotype control, or RMP + anti-CXCR7, 
and stained with Masson  ’  s trichrome (day 14). Data represent the mean values   ±   the SEM. Bars, 20    m .    JEM VOL. 205, February 18, 2008 
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PKH26-labeled cells in the kidney of mice injected with 
RMPs after pretreatment with a neutralizing anti-CXCR4, 
anti-CXCR7, or their isotype-matched control antibody with 
irrelevant specifi  city, or the HLA-I antibody, was evaluated. 
Quantitation of the number of PKH26-labeled cells over the 
total number of renal cells demonstrated a signifi  cantly higher 
percentage of PKH26-labeled cells in the kidney of mice in-
jected with RMPs pretreated with the isotype-matched control 
antibody with irrelevant specifi  city or with the isotype-
matched anti  –  HLA-I antibody in comparison with mice in-
jected with RMPs pretreated with an anti-CXCR4 antibody 
4 d after injury (8.24   ±   2.1% vs. 0.8   ±   0.43%; **, P   <   0.001; 
or 7.32   ±   1.9% vs. 0.8   ±   0.43%; **, P   <   0.001), as well as 14 d 
after injury (7.48   ±   1.95% vs. 0.4   ±   0.31%; **, P   <   0.001; 
or 8.43   ±   1.77% vs 0.4   ±   0.31%; **, P   <   0.001;   Fig. 4, A, B, 
and E  ).   In addition, mice injected with RMPs pretreated with 
the CXCR4 antagonist AMD3100 demonstrated percent-
ages of PKH26-labeled cells comparable to those observed in 
the kidney of mice injected with RMPs pretreated with an 
anti-CXCR4 antibody 4 d after injury (0.7   ±   0.34% vs. 0.8   ±   
0.43%; NS), as well as on day 14 (0.6   ±   0.38% vs. 0.4   ±   
0.31%; NS;   Fig. 4 E  ). Likewise, quantitation of the number of 
PKH26-labeled cells over the total number of renal cells dem-
onstrated a signifi  cantly higher percentage of PKH26-labeled 
cells in the kidney of mice injected with RMPs pretreated 
with the isotype-matched antibody with irrelevant specifi  city 
or the isotype-matched anti  –  HLA-I antibody in comparison 
with mice injected with RMPs pretreated with an anti-CXCR7 
antibody (8.68   ±   2.1% vs. 0.38   ±   0.16%; P   <   0.001 or 7.92   ±   
2.4% vs. 0.38   ±   0.16%; **, P   <   0.001) on day 4 after injury, 
as well as on day 14 (6.9   ±   1.4% vs. 0.65   ±   0.41%; **, P   <   
0.001; or 7.4   ±   1.34% vs. 0.65   ±   0.41%; **, P   <   0.001; 
  Fig. 4, C, D, and F  ). These fi  ndings demonstrate that the 
interaction between SDF-1 with both CXCR4 and CXCR7 
expressed by RMPs is involved in their therapeutic homing in 
injured kidneys. 
  RMP chemotaxis is selectively mediated through CXCR4,
but CXCR7 is required for their transendothelial migration 
and mediates their adhesion to ECs 
  It has already been shown that the SDF-1  –  CXCR4 inter-
action is important for homing and engraftment of HSCs 
(  2  –  7, 26, 27  ), whereas the role of SDF-1  –  CXCR7 inter-
action on these processes is unknown. We therefore hypoth-
esized that SDF-1 could act as a chemotactic agent for homing 
and engraftment of RMPs in injured kidneys via its inter-
action with CXCR4, CXCR7, or both. To this end, the in 
vitro chemotactic activity of SDF-1 on RMPs was evalu-
ated. As shown in   Fig. 5 A  , SDF-1 induced chemotaxis of 
RMPs in a dose-dependent manner, with maximal chemo-
tactic response detectable at 10  –  100 nM SDF-1.   Little or 
no migration to the bottom chamber was noted with 10 nM 
SDF-1 placed in the top and bottom chambers, or in 
the top chamber only, thus demonstrating that SDF-1 was 
chemotactic rather than chemokinetic for RMPs (un-
published data). Of note, pretreatment of RMPs with an 
  RMPs labeled with the red fl  uorescent dye PKH26 were 
injected into the tail vein of glycerol-treated SCID mice after 
pretreatment with a neutralizing anti-CXCR4 antibody, or 
anti-CXCR7 antibody, or their respective isotype-matched anti-
bodies with irrelevant specifi  city. To exclude the possibility 
that circulating RMPs after their coating with antibody were 
simply removed from the circulation, two diff  erent experi-
mental approaches were used. First, two other groups of mice 
were injected with RMPs pretreated with an isotype-matched 
antibody that bind to an unrelated surface molecule such as 
HLA-I, which is highly expressed on the surface of RMPs, as 
also demonstrated in our previous study (  25  ). Second, the ef-
fects of injection of RMPs pretreated with the selective CXCR4 
antagonist AMD3100 were assessed. BUN levels, as well as 
areas of necrosis found 4 d after injury, were signifi  cantly higher 
in mice injected with saline or with PKH26-stained RMPs pre-
treated with either an anti-CXCR4 or -CXCR7 antibody in 
comparison with those found in mice injected with PKH26-
stained RMPs, which had been pretreated with the respective 
isotype-matched antibody with irrelevant specifi  city or the 
anti  –  HLA-I antibody, but comparable to those of mice injected 
with the CXCR4 antagonist AMD3100 (  Fig. 3, C and D  ). 
Accordingly, a signifi  cant reduction in phalloidin staining was 
observed in mice injected with RMPs pretreated with an anti-
CXCR4 antibody (mean fl  uorescence: 47,825   ±   5,822 vs. 
151,680   ±   16,862; P   <   0.05 or 47,825   ±   5,822 vs. 137,221   ±   
23,443; P   <   0.05) or in mice injected with RMPs pretreated with 
an anti-CXCR7 antibody (52,736  ±   3,583 vs. 147,492  ±   22,168; 
P   <   0.05 or 52,736   ±   3,583 vs. 155,654   ±   27,556; P   <   0.05) 
in comparison with the respective control mice injected with 
PKH26-stained RMPs, which had been pretreated with iso-
type-matched antibody with irrelevant specifi  city or the HLA-I 
antibody. In addition, on day 14 after injury, mice injected 
with RMPs pretreated with an anti-CXCR4 or -CXCR7 
antibody displayed BUN levels signifi  cantly higher in compari-
son with those of mice injected with PKH26-stained RMPs, 
which had been pretreated with isotype-matched control anti-
body with irrelevant specifi  city or the anti  –  HLA-I antibody, 
but comparable to those of mice injected with the RMPs pre-
treated with CXCR4 antagonist AMD3100 (  Fig. 3 E  ). Accord-
ingly, evaluation of the fi  brosis score with Masson  ’  s trichrome 
staining in mice injected with RMPs pretreated with an anti-
CXCR4 antibody (fi  brosis score, 2.57   ±   0.18 vs. 0.32   ±   0.17; 
P   <   0.001; or 2.57   ±   0.18 vs. 0.29   ±   0.22; P   <   0.001) or in mice 
injected with RMPs pretreated with an anti-CXCR7 antibody 
(fi  brosis score, 2.83   ±   0.18 vs. 0.58   ±   0.22; P   <   0.001 or 2.74   ±   
0.11 vs. 0.54   ±   0.34; P   <   0.001) demonstrated a higher fi  brosis 
score in comparison with the respective control mice injected 
with PKH26-stained RMPs, which had been pretreated with 
isotype-matched control antibody with irrelevant specifi  city or 
the HLA-I antibody (  Fig. 3 F  ). 
  Neutralization of either CXCR4 or CXCR7 reduces
the number of RMPs engrafted in kidneys with ARF 
  To further investigate the mechanisms of activity of SDF-1  –
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  However, because RMP engraftment into injured renal 
tissues also requires transendothelial migration, the contribu-
tion of CXCR4 and CXCR7 to the SDF-1  –  induced trans-
endothelial migration via a confl  uent human umbilical vein 
EC (HUVEC) monolayer was also assessed. To this end, RMPs 
were labeled with the fl  uorescent dye PKH26 and added 
to transwell culture plates previously cultured with HUVEC 
monolayers. To evaluate the transmigratory potential of a 
chemokine gradient, 10 nM SDF-1 was added to the bottom 
chamber. The exposure of RMPs to 10 nM SDF-1 in the 
bottom chamber signifi  cantly increased transendothelial mi-
gration, as assessed by counting the number of cells/fi  eld (1.7   ±   
0.2 vs. 23.7   ±   2.9 cells/fi  eld; P   <   0.001) and by measuring mean 
fl  uorescence staining by confocal microscopy (  Fig. 5, C  –  E  ). 
As expected, the increase in transendothelial migration was 
suppressed by an anti-CXCR4 antibody added to the top 
chamber, but not by an equal concentration of an isotype-
matched control antibody (3.2   ±   0.2 vs. 22   ±   3 cells/fi  eld; 
P   <   0.001;   Fig. 5, C and D  ). However, the addition of an 
anti-CXCR7 antibody to the top chamber also completely 
inhibited transendothelial migration of RMPs, an eff  ect that was 
not observed in presence of an isotype-matched control anti-
body (2.2   ±   0.1 vs. 20   ±   1.9 cells/fi  eld; P   <   0.001;   Fig. 5, C 
and E  ). These fi  ndings suggest that the interaction of SDF-1 
with CXCR4 is responsible for the recruitment of these cells, 
but SDF-1  –  CXCR7 interaction is also required for their 
transendothelial migration. 
  To further support the contribution of SDF-1  –  CXCR7 
interaction in the transendothelial migration of RMPs, the role 
of both CXCR4 and CXCR7 in their adhesion to ECs was 
examined. It has indeed been reported that SDF-1 can favor 
the adhesion of SCs to ECs (  2  –  7  ). To solve this question, 
RMPs labeled with the red fl  uorescent dye PKH26 were ap-
plied to HUVEC monolayers. A representative image showing 
PKH26-labeled RMPs (red) adhesion to the EC monolayer 
stained with Ulex Europeus 1 Lectin (green) is shown in   Fig. 5 F  . 
Pretreatment of PKH26-labeled RMPs with an anti-CXCR7 
antibody blocked the adhesion of RMPs to HUVEC mono-
layers, as assessed by counting the number of cells/fi  eld (6.6   ±   
0.9 vs. 84   ±   6 cells/fi  eld; P   <   0.001) and by measuring mean 
fl  uorescence staining by confocal microscopy (  Fig. 5, G and H  ). 
In contrast, pretreatment of RMPs with an anti-CXCR4 
  antibody did not have any eff  ect (87.3   ±   5.2 vs. 89.2   ±   3.7 
cells/fi  eld; NS;   Fig. 5, G and H  ). Collectively, these results 
suggest that CXCR7, but not CXCR4, mediates adhesion of 
RMPs to ECs, and is therefore responsible for their transendo-
thelial migration. 
  CXCR7, but not CXCR4, is responsible for RMP survival 
  It has been shown that HSCs from adult subjects depend 
upon SDF-1 not only for their migration/homing, but also for 
their survival and proliferation (  2  –  7  ). We therefore investigated 
the eff  ects of SDF-1 on the survival/proliferation of RMPs. 
SDF-1 exhibited a limited eff  ect on DNA synthesis under 
basal conditions, but it signifi  cantly enhanced the survival/
proliferation of RMPs cultured in presence of H  2  O  2   (  Fig. 6 A  ).   
anti-CXCR4 neutralizing antibody completely blocked the 
chemotactic response of RMPs (  Fig. 5 B  ), whereas pre-
treatment of RMPs with an anti-CXCR7 neutralizing anti-
body had no eff  ect on their chemotactic response (  Fig. 5 B  ). 
Collectively, these results suggest that of the two SDF-1 
receptors, only CXCR4 is responsible for the migratory re-
sponse of RMPs. 
    Figure 4.     Both CXCR4 and CXCR7 are required for RMP recruit-
ment and engraftment into injured renal tissue.  (A)  Representative 
micrograph of kidney sections of mice with induced ARF injected with 
PKH26-labeled RMPs (red) pretreated with an IgG2a-isotype control 
antibody and stained with LTA (green) on day 14. (B) Representative 
micrograph of kidney sections of mice with induced ARF injected with 
PKH26-labeled RMPs (red) pretreated with an anti-CXCR4 antibody and 
stained with LTA (green) on day 14. (C) Representative micrograph of 
kidney sections of mice with induced ARF injected with PKH26-labeled 
RMP (red) + IgG-isotype control antibody and stained with LTA (green) on 
day 14. (D) Representative micrograph of kidney sections of mice with 
induced ARF injected with PKH26-labeled RMPs (red) pretreated with an 
anti-CXCR7 antibody and stained with LTA (green) on day 14. To-Pro-3 
counterstains nuclei. Bars, 20     m. (E) Quantitative comparison of the 
number of PKH26-labeled cells over the total number of tissue cells 
between kidneys obtained from mice treated with PKH26-labeled RMP + 
IgG2a-isotype control antibody, PKH26-labeled RMP + IgG2a-anti-HLA-I 
antibody, PKH26-labeled RMP + AMD3100, or PKH26-labeled RMP + anti-
CXCR4 antibody on day 14 after glycerol injection. a vs. b, c vs. d: NS; a vs. c, 
b vs. c, a vs. d, b vs. d: P   <   0.001  .   (F) Quantitative comparison of the 
number of PKH26-labeled cells over the total number of tissue cells 
between kidneys obtained from mice treated with PKH26-labeled RMP + 
IgG-isotype control antibody, PKH26-labeled RMP + IgG-anti-HLA-I 
antibody, or PKH26-labeled RMP + anti-CXCR7 antibody on day 14 after 
glycerol injection. a vs. b: NS; a vs. c, b vs. c: P   <   0.001.     JEM VOL. 205, February 18, 2008 
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of 10 nM SDF-1 (47   ±   12% vs. 0.7   ±   0.3%; P   <   0.001; and 
mean fl  uorescence 12,738   ±   1,534 vs. 281.5   ±   57; P   <   0.001; 
  Fig. 6 B ). Blocking the CXCR4 receptor with an anti-CXCR4 
mAb did not display any eff  ect on either SDF-1  –  mediated 
enhancement of RMP survival/proliferation, as assessed by 
evaluation of [  3  H]thymidine incorporation (  Fig. 6 C  ) or the 
percentage of apoptotic cells in comparison with cells treated 
with the isotype-matched control antibody, as assessed by the 
TUNEL technique (0.3   ±   0.6% vs. 0.9   ±   0.1%; NS; mean 
fl  uorescence, 210   ±   48.76 vs. 204.7   ±   50.5; NS;   Fig. 6 D  ). 
To evaluate whether the SDF-1  –  mediated increase of DNA 
synthesis was related to a reduction of apoptosis, the amount 
of DNA fragmentation on RMPs treated with H  2  O  2   in the 
presence or absence of increasing concentrations of SDF-1 
(1  –  100 nM) was assessed by using the TUNEL technique, and 
apoptotic cells were quantifi  ed by counting their percentages 
over the total number of cells, as well as by measuring mean 
fl  uorescence of TUNEL staining by confocal microscopy. 
The addition in RMP cultures of H  2  O  2   up-regulated DNA 
fragmentation, an eff  ect that was completely reverted in presence 
    Figure 5.     RMP migration is mediated through CXCR4, but CXCR7 is required for transendothelial migration and mediates EC adhesion.  
(A) Dose-dependent migration of RMPs in response to SDF-1. Results are expressed as the mean   ±   the SEM of triplicate assessment. One representative of 
three independent experiments is shown. *, P   <   0.05; **, P   <   0.001. (B) RMP migration is reverted by pretreatment with anti-CXCR4 neutralizing antibody, 
but not by an anti-CXCR7 neutralizing antibody. Results are expressed as the mean   ±   the SEM as assessed in four independent experiments. **, P   <   0.001. 
(C) Transendothelial migration of RMPs is reverted by pretreatment with either an anti-CXCR4 or an anti-CXCR7 neutralizing antibody. One representative 
of three independent experiments is shown. (D) Quantitation of transendothelial migration of RMPs. Results are expressed as the mean   ±   the SEM of 
fl  uorescence intensity as observed in four independent experiments. a vs. b and b vs. c: P   <   0.05; a vs. c: NS. (E) Quantitation of transendothelial migration 
of RMPs. Results are expressed as the mean   ±   the SEM of fl  uorescence intensity as observed in four independent experiments. a vs. b and b vs. c: P   <   0.05; 
a vs. c: NS. (F) HUVECs were stained with Ulex europeus I lectin (green) to visualize the EC monolayer. To-Pro-3 was used to counterstain nuclei. 
(G) PKH26-labeled RMPs (red) were cultured in presence or absence of an isotype control antibody, an anti-CXCR7 antibody or an anti-CXCR4 neutralizing 
antibody. One representative of three independent experiments is shown. (H) Quantitation of RMP adhesion to HUVEC monolayers. Results are expressed 
as the mean   ±   the SEM of fl  uorescence intensity as observed in four independent experiments. **, P   <   0.001. Bars; (C and F) 50     m; (G) 100    m.   486 CXCR4 AND CXCR7 IN THERAPEUTIC HOMING OF RENAL STEM CELLS | Mazzinghi et al.
In contrast, treatment of RMPs with an anti-CXCR7 antibody 
completely reverted the SDF-1  –  mediated stimulation of DNA 
synthesis (  Fig. 6 E  ) and increased the percentage of apoptotic 
cells in comparison with cells treated with the isotype-matched 
control antibody (35   ±   2.6% vs. 0.8   ±   0.4%; P   <   0.001;   Fig. 6 F  ), 
the mean fl  uorescence being 15,467   ±   3,445 vs. 272.6   ±   
49.3; P   <   0.001. In addition, although H  2  O  2   addition was as-
sociated with increased mRNA levels of the proapoptotic 
gene Bax-2, the addition of SDF-1 to RMPs treated with 
H  2  O  2   restored Bax-2 basal levels, an eff  ect that was com-
pletely reverted by an anti-CXCR7 (  Fig. 6 G  ), but not by an 
anti-CXCR4 antibody (not depicted). Collectively, these re-
sults indicate that SDF-1 enhances RMP survival through its 
interaction with CXCR7, whereas the SDF-1  –  CXCR4 in-
teraction is not involved in this process. 
    DISCUSSION   
  Cells can reach specifi  c target tissues through the general cir-
culation by diff  erent mechanisms. Homing has been studied 
extensively both in vitro and in vivo with diff  erent cell types, 
such as leukocytes or HSCs (  2  –  7, 26-29  ), and it is believed to 
rely on adhesion molecules and chemokine receptors via a multi-
step cascade, consisting of a rolling process followed by fi  rm 
adhesion and transendothelial migration into the surrounding 
tissue (  2  –  7, 26  –  32  ). The repertoire and the level of chemo-
kine expression by the target tissue, as well as expression of 
the respective receptors on SCs, infl  uence the effi   ciency of 
homing (  2  –  7  ). The critical role of SDF-1 in HSC homing has 
been suggested by several studies (  2  –  7  ). Accordingly, it had 
been demonstrated that SDF-1 regulates traffi   cking of CD34  +   
  hematopoietic stem/progenitor cells, as well as pre  –  B and T 
lymphocytes (  2  –  7  ). However, in recent years, evidence has been 
accumulated to suggest that SDF-1 is also a crucial regulator 
of SC biology in several tissue-committed stem/progenitor 
cells, such as primordial germ cells, skeletal muscle satellite pro-
genitor cells, neural SCs, liver oval SCs, and retinal pigment 
epithelium progenitors (  3  –  5  ). 
  In humans, RMPs have recently been characterized as a 
population of cells localized at the urinary pole of the Bow-
man  ’  s capsule that can diff  erentiate into tubular cells of diff  er-
ent portions of the nephron (  25  ). When injected i.v., human 
RMPs have been shown to induce a complete recovery of 
both renal structure and function in rhabdomyolysis-induced 
ARF of SCID mice (  25  ). The reason for the therapeutic eff  ect 
of RMPs is likely to be ascribed to the ability of these cells to 
    Figure 6.     Effect of SDF-1 on RMP survival is mediated by CXCR7, 
but not by CXCR4.   (A) SDF-1 up-regulates DNA synthesis in basal condi-
tions and rescues DNA synthesis after H  2 O 2   treatment. Results are ex-
pressed as the mean   ±   the SEM of triplicate assessment, as assessed in 
four independent experiments. (B) A representative micrograph of TUNEL 
immunostaining demonstrates that SDF-1 rescues apoptosis (green) 
induced by H  2 O 2   treatment. One representative of three independent ex-
periments is shown. To-Pro-3 counterstains nuclei. (C) Lack of effect of a 
neutralizing anti-CXCR4 antibody on SDF-1  –  mediated prosurvival effect. 
Results are expressed as the mean   ±   the SEM of triplicate assessment, as 
assessed in four independent experiments. (D) A representative micro-
graph of TUNEL immunostaining (green) demonstrates that SDF-1  –  mediated 
rescue from apoptosis induced by H  2 O 2   treatment is not neutralized 
by an anti-CXCR4. One representative of three independent experiments 
is shown. To-Pro-3 counterstains nuclei. (E) A neutralizing anti-CXCR7 
antibody reverts the prosurvival effect of SDF-1. Results are expressed as 
the mean   ±   the SEM of triplicate assessment, as assessed in four indepen-
dent experiments. (F) A representative micrograph of TUNEL immuno-
staining (green) demonstrates that SDF-1  –  mediated rescue from 
apoptosis induced by H  2 O  2  treatment is completely reverted by an anti-
CXCR7 antibody. One representative of three independent experiments is 
shown. To-Pro-3 counterstains nuclei. (G) The SDF-1-CXCR7 axis modu-
lates Bax transcription in response to H  2 O 2  . Results are expressed as the 
mean   ±   the SEM of triplicate assessment, as assessed in four independent 
experiments. a vs. c, e vs. f, c vs. e, b vs. d, b vs. f: P   <   0.05; a vs. b, c vs. d, 
d vs. f: NS. Bars, 20    m.   
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CXCR4 or CXCR7 appeared to be inhibitory, suggesting that 
CXCR7 was in some way involved in the process of migra-
tion at the endothelial level. This possibility was further sup-
ported by the observation that only blocking CXCR7, but 
not CXCR4, inhibited the adhesion of RMPs to ECs in vitro. 
Thus, it appears that in the therapeutic homing of RMPs in 
injured kidneys of SCID mice, the SDF-1  –  CXCR4 inter-
action is responsible for the recruitment of RMPs, whereas 
the binding of SDF-1 to CXCR7 is required for RMP adhesion 
to ECs, and therefore is essential for their transendothelial 
migration. Interestingly, however, CXCR4 was also involved 
in transendothelial migration, suggesting that this chemokine 
receptor probably plays a role by fulfi  lling an   “  interceptor  ”   
function and regulating the translocation of SDF-1 across the 
endothelium, as previously demonstrated also in BM-derived 
endothelium (  27  ). 
  In previous studies, SDF-1 has also been implicated not 
only in SC adhesion but also in the induction of SC prolifera-
tion/survival (  4  –  7, 34, 35  ). In addition, SDF-1 was found to 
be critical for the normal development of several organs, sug-
gesting that this chemokine may play a role in the migration/
adhesion/proliferation/survival of most adult progenitor cells 
(  4  –  6  ). Interestingly, apoptotic cell death of RMP induced by 
H  2  O  2   can be reverted by treatment with SDF-1. H  2  O  2   gen-
erated during hypoxia/reoxygenation and ischemia/reperfusion 
injury is an important mediator of cell death induced dur  ing 
renal ischemia (  36, 37  ), as well as in myohemoglobinuric re-
nal injury (  36, 38  ), suggesting that SDF-1 production might 
play a critical role in RMP protection after kidney injury. 
SDF-1 has previously been thought to mediate all its func-
tions exclusively via CXCR4 (  4  –  6  ). The results of this study 
clearly demonstrate that, at least in RMP, the survival pro-
cess induced by SDF-1 is mediated by CXCR7, but not by 
CXCR4. This fi  nding is consistent with the results of another 
study suggesting that the survival/antiapoptotic eff  ect of SDF-1 
on mesenchymal SCs was not mediated through CXCR4 (  35  ). 
In addition, some suggestions of discrepant CXCR4 expression 
and SDF-1 responsiveness already exist in the literature. For 
example, previous studies demonstrated that adhesion of E11 
fetal liver cells to BM endothelium can be neutralized by 
anti  –  SDF-1 antibodies, despite the fact that the E11 fetal liver 
cells do not migrate in response to SDF-1 (  39  ). Collectively, 
these fi  ndings not only provide an explanation for the mech-
anisms that allow the therapeutic homing of RMPs in injured 
kidney tissues, but may also require a reexamination of much 
of the previous work that presumed a mutually exclusive bio-
logical interaction between SDF-1 and CXCR4. Indeed, the 
fi  nding that the adhesion and survival eff  ect of SDF-1 on 
RMPs was selectively mediated through CXCR7 suggests that 
CXCR7 might play an important, even if still unexplored, 
role in other progenitor/SC physiology (  2  –  7, 26  –  40  ). A great 
deal is known about the eff  ects of SDF-1 on SC functions, 
and this information has been used for modulating these cells 
in the clinical setting, particularly for enhancing transplanta-
tion eff  ectiveness (  3  ). The results of this study suggest that not 
only CXCR4 but also CXCR7 is required for the effi   cient 
reach and colonize the kidney, depending in turn on EC ad-
hesion and extravasation. 
  In this study, we demonstrate that among all known che-
mokine receptors, RMPs exhibited high expression of the 
two receptors for SDF-1, CXCR4, and CXCR7, which sug-
gests that these cells may be responsive to the activity of this 
chemokine. Indeed, not only did RMPs express mRNA and 
protein for both receptors, but they also reacted with SDF-1 
according to a two-site binding model (  7  ). Notably, this bind-
ing was only partially inhibited by cell pretreatment with a 
selective CXCR4 antagonist and partially displaced by I-TAC, 
which is in agreement with previously reported results show-
ing the ability of CXCR7 to bind both SDF-1 and I-TAC (  7  ). 
Moreover, we observed an increased expression of SDF-1 in 
renal ECs and epithelial cells surrounding injured tubular 
structures, which is in agreement with SDF-1 up-regulation 
reported in ischemia/reperfusion-induced ARF in rats (  33  ). 
In our model, up-regulation of SDF-1 expression and pro-
duction was related to the exposure of these cells to toxic 
amounts of hemoglobin and myoglobin resulting from rhab-
domyolysis. A similar eff  ect may also occur in human patho-
logical conditions, resulting in ARF related to acute and massive 
red blood cells and skeletal muscle cell destruction. When 
human RMPs were injected into SCID mice on the same day 
as the injury, there was a substantial reduction of the severity 
of ARF and a complete recovery of renal function in com-
parison with mice treated with saline. In agreement with a 
central role of SDF-1 in RMP therapeutic homing to injured 
renal tissue, neutralization of CXCR4 completely blocked 
the regenerative capacity of RMPs, caused by a substantially 
decreased recruitment of these cells in injured renal tissue. 
Surprisingly, however, both the in vivo regenerative capacity 
of RMPs and their engraftment in injured kidneys was also 
abolished when these cells were injected with a neutralizing 
anti-CXCR7 antibody, suggesting that not only CXCR4 but 
also CXCR7 expression is critical for the therapeutic homing 
of RMPs in injured renal tissue. These antibody-mediated 
inhibitory eff  ects did not simply refl  ect the removal of anti-
body-coated RMPs from the circulation. Indeed, no inhibi-
tory eff  ects were obtained by using the same cells pretreated 
with antibody specifi  c for HLA-I, which is a molecule that is 
highly expressed on the surface of RMPs (  25  ). More impor-
tantly, RMP cells pretreated with AMD3100, which is a selec-
tive antagonist of CXCR4, exhibited eff  ects quite comparable 
to those exerted by RMP cells pretreated with anti-CXCR4 
or -CXCR7 antibody. 
  To understand the respective roles of CXCR4 and CXCR7 
on the regenerative activity of RMPs, the migration of RMPs 
was evaluated in vitro by a transwell assay, which was already 
proven as a reliable indicator of the mechanisms that govern 
cellular traffi   cking in vivo (  34  ). Only blocking of CXCR4, 
but not of CXCR7, inhibited the chemotactic activity of 
SDF-1 on RMPs, suggesting that only CXCR4 was required 
for the recruitment of human RMP. However, when the trans-
endothelial migration of RMPs via a confl  uent HUVEC mono-
layer in response to SDF-1 was assessed, blocking of either 488 CXCR4 AND CXCR7 IN THERAPEUTIC HOMING OF RENAL STEM CELLS | Mazzinghi et al.
was determined using a      counter. Data were analyzed using the computer 
program Ligand (  44  ). 
  SDF-1 ELISA assay.     Mouse RPTECs were plated in 24-well culture plates 
(5   ×   10  4   cells/well) and treated with 100 ng/ml of hemoglobin (Sigma-
Aldrich) or 100 ng/ml myoglobin (Sigma-Aldrich) for 24 h at 37  °  C. After 
incubation, supernatants were collected and RPTEC pellets were recov-
ered to assess SDF-1 protein and mRNA levels. SDF-1 protein was assessed 
by an immunoenzymatic assay (R  &  D Systems) following the manufac-
turer  ’  s instructions. 
  Xenograft in SCID mouse model of ARF.     Models of rhabdomyolysis-
induced ARF were performed in female SCID mice (Harlan), as previously 
described (  25  ), by intramuscular injection with hypertonic glycerol (8 ml/kg 
body wt of a 50% glycerol solution; Sigma-Aldrich) into the inferior hind 
limbs at day 0. Animal experiments were authorized by Ministero della Salute 
of Italy (Dipartimento della Sanit  à   Pubblica e Veterinaria) and performed in 
adherence to the National Institutes of Health Guide for the Care and Use 
of Laboratory Animals. 9 groups of mice on day 0 received an i.v. injection 
into the tail vein as follows: group 1,   n   = 50 mice, saline; group 2,   n   = 40 
mice, PKH26-stained RMPs (0.75   ×   10  6   cells 4 h after glycerol injection and 
0.75   ×   10  6   cells 20 h after glycerol injection); group 3,   n   = 30 mice, PKH26-
stained RMPs pretreated with mouse IgG2a isotype control antibody (R  &  D 
Systems; 0.75   ×   10  6   cells 4 h after glycerol injection and 0.75   ×   10  6   cells 20 h 
after glycerol injection); group 4,   n   = 30 mice, PKH26-stained RMPs pre-
treated with an anti-CXCR4 neutralizing antibody (R  &  D Systems; 0.75   ×   10  6   
cells 4 h after glycerol injection and 0.75   ×   10  6   cells 20 h after glycerol 
injection); group 5,   n   = 30 mice, PKH26-stained RMPs pretreated with 
rabbit IgG isotype control antibody (R  &  D Systems; 0.75   ×   10  6   cells 4 h after 
glycerol injection and 0.75   ×   10  6   cells 20 h after glycerol injection); group 6, 
  n   = 30 mice, PKH26-stained RMPs pretreated with an anti-CXCR7 neu-
tralizing antibody (Abcam; 0.75   ×   10  6   cells 4 h after glycerol injection and 
0.75   ×   10  6   cells 20 h after glycerol injection); group 7,   n   = 20 mice, PKH26-
stained RMPs pretreated with rabbit IgG anti  –  HLA-I antibody (Santa Cruz 
Biotechnology; 0.75   ×   10  6   cells 4 h after glycerol injection and 0.75   ×   10  6   
cells 20 h after glycerol injection); group 8,   n   = 16 mice, PKH26-stained 
RMP pretreated with mouse IgG2a anti  –  HLA-I antibody (Sigma-Aldrich; 
0.75   ×   10  6   cells 4 h after glycerol injection and 0.75   ×   10  6   cells 20 h after 
glycerol injection); and group 9,   n   = 20 mice, PKH26-stained RMPs pre-
treated with 50     M AMD3100 (Sigma-Aldrich; 0.75   ×   10  6   cells 4 h after 
glycerol injection and 0.75   ×   10  6   cells 20 h after glycerol injection). RMPs 
were labeled with the PKH26 Red Fluorescence Cell Linker kit (Sigma-
Aldrich) immediately before injection. Pretreatment with neutralizing anti-
bodies was performed by incubating cells with antibodies (10   μ  g/10  6   cells) 
for 30 min on ice. For each group, 30 min after each i.v. injection, mice 
were treated i.p. with 10   μ  g/mouse of the respective neutralizing antibody. 
At least 10 mice were killed for each group of treatment at 4, 6, 9, or 14 d, and 
BUN levels were measured in heparinized blood by the Aeroset c8000 test 
(Abbott). Normal range in our experiments was between 30 and 37 mg/dl, 
as calculated in 10 additional untreated mice (day 0). BUN levels that exceeded 
40 mg/dl were considered abnormal. 
  For evaluation of SDF-1 secretion, ARF was induced in an additional 
group of 32 mice, as described in the previous paragraph. Mice were killed 
on day 0, 1, 2, 3, 4, 6, 10, or 14, and their kidneys were removed and 
stained with phalloidin and SDF-1 (  n   = 4 at each time point). 
  Renal morphology.     5-  μ  m-thick kidney sections of mice killed at day 14 
were fi  xed in ethanol and stained with a Masson-Goldner trichromic kit (Bio-
Optica) to evaluate the fi  brosis of cortical interstitium. Nonoverlapping fi  elds 
of the entire section (up to 20 fi  elds for each mouse) were independently 
analyzed at high magnifi  cation using a 20  ×   objective by two observers. 
The severity of renal scarring was assessed as follows: normal tubulointersti-
tium scored 0; mild tubular atrophy with interstitial edema or fi  brosis 
  aff  ecting up to 25% of the fi  eld scored 1; moderate tubular atrophy with in-
terstitial edema or fi  brosis aff  ecting 25  –  50% of the fi  eld scored 2; and   severe 
delivery of RMPs to injured kidneys in response to SDF-1 
for cell therapy of ARF, a property that might be shared by 
other types of SCs, with important implications for the set up 
of SC-based therapies. 
    MATERIALS AND METHODS   
  Antibodies.     The following antibodies were used: anti-CXCR4 (clone 12G5, 
mouse IgG2a; R  &  D Systems), anti-CXCR7 (rabbit polyclonal IgG directed 
toward the second extracellular domain; Abcam; rabbit polyclonal IgG di-
rected toward the third cytoplasmic loop; Affi   nity BioReagents), anti-SDF-1 
(clone 179018, mouse IgG1; R  &  D Systems), anti-vWf (polyclonal IgG; Dako), 
mouse anti  –  human HLA-I (IgG2a; Sigma-Aldrich), rabbit anti  –  human 
HLA-I (IgG; Santa Cruz Biotechnology), mouse IgG2a isotype control (clone 
20102; R  &  D Systems), and rabbit IgG isotype control (R  &  D Systems). Alexa 
Fluor 546  –  labeled goat anti  –  mouse IgG1, Alexa Fluor 488  –  labeled goat anti  –
  mouse IgG2a, and Alexa Fluor 488  –  labeled goat anti  –  rabbit IgG were ob-
tained from Invitrogen. 
  Isolation and culture of RMPs.     RMPs were obtained as previously de-
scribed (  25  ) from fi  ve patients who underwent radical nephrectomy because 
of renal cell carcinoma. Macroscopically normal portions of renal tissue were 
obtained from the pole opposite the tumor, in accordance with the recom-
mendations of the Ethical Committee of the Azienda Ospedaliero-Universitaria 
Careggi, Florence, Italy on human experimentation. 
  Cell cultures.     Primary cultures of mouse RPTECs were obtained as previ-
ously described (  41  ). HUVECs were obtained from Lonza and cultured 
following manufacturer  ’  s instructions. 
  Confocal microscopy.     Confocal microscopy was performed on 5-    m 
sections of renal frozen tissues or on cells cultured on chamber slides by using 
a LSM 510 META laser confocal microscope (Carl Zeiss, Inc.), as previously 
described (  42  ). 
  Staining with FITC-labeled Ulex europeus I lectin (Sigma-Aldrich), 
FITC-labeled Lotus tetragonolobus agglutinin (LTA; Vector Laboratories), 
and Alexa Fluor 488 phalloidin (Invitrogen) were performed following 
  manufacturer  ’  s instructions. For quantifi  cation of necrosis in glycerol-injected 
SCID mice, four random fi  elds of kidney tissue stained for phalloidin were 
recorded from each mouse for each group of treatments at day 4, using a 20  ×   
objective. All random scans of the kidney tissue were recorded at the same 
photomultiplier tube, pinhole aperture, and laser voltage setting and ana-
lyzed using LSM 510 confocal microscopy software 3.0. 
  Real-time quantitative RT-PCR.     TaqMan RT-PCR was performed as 
previously described (  25  ). CXCR1, CXCR2, CXCR5, CXCR6, CXCR7, 
CX3CR1, CCR1, CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, CCR8, 
CCR9, CCR10, SDF-1, and Bax quantitation was performed using Assay 
on Demand kits (Applied Biosystems). CXCR4 primers and probes were as 
follows: probe VIC 5    -ACACTTCAGATAACTACACCGAGGAAATG-
GGC-3    , forward: 5    -CACCGCATCTGGAGAACCA-3    , and reverse: 
5    -CTTCATGGAGTCATAGTCCCCTG-3    . CXCR3-A and CXCR3-B 
primers and probes were previously described (  43  ). 
  Binding assays.     Binding assays were performed as previously described (  43  ). 
In brief, cells were plated in 24-well culture plates and washed twice with 
washing buff  er (0.5 M NaCl, 50 mM Hepes, 1 mM CaCl  2  , 5 mM MgCl  2  , 
and 1% BSA, pH 7.2), and incubated in triplicate in binding buff  er (25 mM 
Hepes, 140 mM NaCl, 1 mM CaCl  2  , 5 mM MgCl  2  , and 0.2% BSA, pH 7.1) 
with a constant concentration (20 pM) of   125  I-labeled SDF-1 (PerkinElmer) 
in the presence of increasing concentrations of unlabeled chemokines, and/
or 50     M of the CXCR4 selective antagonist AMD3100 (Sigma-Aldrich). 
Incubations took place in 200   μ  l binding buff  er. After incubation at room 
temperature for 2 h, binding buff  er was aspirated and cells were washed once 
in PBS (without Ca and Mg) and lysed in 0.2 ml 0.5 N NaOH. Radioactivity JEM VOL. 205, February 18, 2008 
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